Predictors of injecting cessation among a cohort of people who inject drugs in Tijuana, Mexico

Drug and Alcohol Dependence
Danielle HoryniakTommi L Gaines

Abstract

Little is known about the cessation of injecting drug use (IDU) among people who inject drugs (PWID) in low and middle-income settings, where access to effective interventions for reducing drug use (e.g., opioid substitution treatment; OST), may be limited. We measured the incidence and identified predictors of IDU cessation among a cohort of PWID in Tijuana, Mexico. Data were drawn from 621 participants in Proyecto El Cuete IV, a prospective cohort of PWID recruited in 2011 and interviewed biannually to 2016. A multivariable Extended Cox model was constructed to identify socio-demographic, drug use, risk environment and health-related predictors of IDU cessation (no IDU for ≥six months). 141 participants (23%) reported at least one IDU cessation event during follow-up. The crude IDU cessation rate was 7.3 per 100 person-years (95% Confidence Interval [CI]: 6.2-8.7). IDU cessation was negatively associated with injecting at least daily on average and heroin/methamphetamine co-injection in the past six months, and positively associated with testing HIV positive at baseline, being on methadone maintenance therapy in the past six months, and recent arrest. Concern for personal safety was also independently associated with IDU cess...Continue Reading

References

Jun 7, 2003·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Peter J DavidsonAndrew R Moss
Oct 1, 2005·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Colin SteensmaElise Roy
Apr 11, 2006·Substance Use & Misuse·Kimberly C BrouwerSteffanie A Strathdee
Feb 6, 2008·Journal of Immigrant and Minority Health·K C BrouwerS A Strathdee
Sep 27, 2008·Lancet·Bradley M MathersUNKNOWN 2007 Reference Group to the UN on HIV and Injecting Drug Use
Apr 24, 2009·Drug and Alcohol Dependence·Robin A PolliniSteffanie A Strathdee
Jun 13, 2009·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Melanie L RuschStefanie A Strathdee
Mar 2, 2010·Lancet·Bradley M MathersUNKNOWN 2009 Reference Group to the UN on HIV and Injecting Drug Use
Feb 16, 2011·American Journal of Epidemiology·Becky L GenbergShruti H Mehta
Feb 22, 2012·Perspectives in Clinical Research·Priya Ranganathan, C S Pramesh
Apr 5, 2013·Bulletin of the World Health Organization·Bradley M MathersMathew Hickman
Jun 8, 2013·The International Journal on Drug Policy·Carol StrikeChristopher Smith
Dec 18, 2013·The International Journal on Drug Policy·Ryan McNeilWill Small
Feb 4, 2014·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Angela M RobertsonSteffanie A Strathdee
Jul 24, 2014·Journal of Psychoactive Drugs·Linda WeissDavid Vlahov
Oct 5, 2014·The International Journal on Drug Policy·Miguel PinedoVictoria D Ojeda
Oct 11, 2014·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Tommi L GainesKimberly Brouwer
Feb 12, 2015·Journal of the International AIDS Society·Eileen V PitpitanThomas L Patterson
Jul 1, 2015·The Lancet Infectious Diseases·Alicia PiñeirúaCarlos Del Rio
Sep 25, 2015·Journal of Studies on Alcohol and Drugs·Miguel PinedoVictoria D Ojeda
Oct 8, 2015·Substance Use & Misuse·Meredith C MeachamScott C Roesch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.